EUVIMEDEUVIMED entdecken
Open Access

Comparison of Vinorelbine-Cisplatin with Gemcitabine-Cisplatin in Patients with Advanced Non-Small Cell Lung Cancer

Sevket Ozkaya, Serhat Findik, Oguz Uzun, Atilla Guven Atici, Levent Erkan

Clinical medicine. Circulatory, respiratory and pulmonary medicine · 2008

DOI: 10.4137/ccrpm.s578 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical medicine. Circulatory, respiratory and pulmonary medicine, 2008. Verfasst von Sevket Ozkaya und 4 weiteren Autor:innen. Beteiligte Einrichtung: Specialist. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

The objective of this trial was to compare cisplatin-plus-vinorelbine regimen with cisplatin-plus-gemcitabine regimen in patients with stage IIIB-IV non-small cell lung cancer (NSCLC). Patients and Methods Chemonaive patients with stage IIIB-IV NSCLC received either vinoelbine 30 mg/m 2 (days 1 and 8) plus cisplatin 80 mg/m 2 (day 1) every 21 days (VC arm) or gemcitabine 1250 mg/m 2 (days 1 and 8) plus cisplatin 80 mg/m 2 (day 1) every 21 days (GC arm).

Results

One hundred thirtyfour patients (67 VC and 67 GC) were included to the study. Overall response rates for the VC arm (31.2%) were not significantly different from that of the GC arm (34.3%). There were no differences in overall survival and one-year survival rates. Median survival and one-year survival rates for the VC and GC groups were 10.6 and 11.5 months, 45% and 46.8%, respectively. Grade 3-4 thrombocytopenia was significantly higher on the GC arm (VC 1.4% v GC 8.9%, p < 0.05), as was febrile neutropenia on the VC arm (VC 8.9% v GC 1.4%, p < 0.05).

Conclusion

VC and GC demonstrated similar efficacy but there were differences in toxicity profiles.

Schlagwörter

Stichwörter der Autor:innen

cisplatingemcitabinemedian survivalnon-small cell lung cancertoxicityvinorelbine

Autor:innen und Institutionen

  • Specialist.

Zitieren

APA

Ozkaya, S., Findik, S., Uzun, O., Atici, A. G., & Erkan, L. (2008). Comparison of Vinorelbine-Cisplatin with Gemcitabine-Cisplatin in Patients with Advanced Non-Small Cell Lung Cancer. Clinical medicine. Circulatory, respiratory and pulmonary medicine. https://doi.org/10.4137/ccrpm.s578

Vancouver

Ozkaya S, Findik S, Uzun O, Atici AG, Erkan L. Comparison of Vinorelbine-Cisplatin with Gemcitabine-Cisplatin in Patients with Advanced Non-Small Cell Lung Cancer. Clinical medicine. Circulatory, respiratory and pulmonary medicine. 2008. doi:10.4137/ccrpm.s578

BibTeX
@article{Ozkaya2008,
  author = {Ozkaya, Sevket and Findik, Serhat and Uzun, Oguz and Atici, Atilla Guven and Erkan, Levent},
  title = {Comparison of Vinorelbine-Cisplatin with Gemcitabine-Cisplatin in Patients with Advanced Non-Small Cell Lung Cancer},
  journal = {Clinical medicine. Circulatory, respiratory and pulmonary medicine},
  year = {2008},
  doi = {10.4137/ccrpm.s578}
}
Kostenlos starten →